{
  "trial_id": "NCT01560663",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Informed consent form signed",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Female with pathologically confirmed diagnosis of primary invasive operable breast cancer, stage IIa-IIIc",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Tumors \u2265 2cm",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Triple negative phenotype patients",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age 18-75 years",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Adequate performance status (ECOG <2)",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Adequate renal and liver function and bone marrow reserve",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Clinical or radiologic evidence of Metastatic disease",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Prior or concurrent anti-cancer therapy for current disease",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "Patient is a postmenopausal woman with HER2-positive and ER/PR-negative breast cancer, stage unknown. She has adequate performance status and renal and liver function.",
  "_meta": {
    "topic_id": "25",
    "trial_id": "NCT01560663",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}